- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/39 - PancreasIslets of Langerhans
Patent holdings for IPC class A61K 35/39
Total number of patents in this class: 852
10-year publication summary
|
71
|
73
|
78
|
93
|
81
|
76
|
86
|
76
|
68
|
34
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ViaCyte, Inc. | 180 |
37 |
| Vertex Pharmaceuticals Incorporated | 1599 |
34 |
| Children's Medical Center Corporation | 1865 |
28 |
| Janssen Biotech, Inc. | 1548 |
21 |
| President and Fellows of Harvard College | 5972 |
20 |
| The Regents of the University of California | 19887 |
19 |
| Sana Biotechnology, Inc. | 158 |
17 |
| Massachusetts Institute of Technology | 10041 |
15 |
| CRISPR Therapeutics AG | 362 |
15 |
| City of Hope | 988 |
14 |
| Cornell University | 3301 |
11 |
| RegenLab USA LLC | 73 |
11 |
| Regents of the University of Minnesota | 2690 |
10 |
| Seraxis, Inc. | 18 |
10 |
| Wake Forest University Health Sciences | 721 |
10 |
| Yeda Research and Development Co. Ltd. | 1339 |
10 |
| Accelerated Biosciences Corp. | 39 |
9 |
| The Salk Institute for Biological Studies | 445 |
9 |
| University of Louisville Research Foundation, Inc. | 720 |
9 |
| Orgenesis Ltd. | 12 |
8 |
| Other owners | 535 |